FACTORS WHICH MAY INFLUENCE THE EFFECTIVENESS OF L-ASPARAGINASES AS TUMOR INHIBITORS 1965).
In other experiments a technique measuring the conversion of 14C asparagine to aspartic acid has been employed. Incubation mixtures consist of 1a8 X 10 2 M sodium borate, 4-6 x 10 2M sodium chloride, 2O x 1 3 M potassium chloride and 8-0 x 10-4 M calcium chloride (pH 7.7) and known concentrations of asparagine (5 x 10-3 to 2 x 10-6 M) with a quantity of 14C label, usually 0-2 ,uCi/ml. (1-asparagine-_4C, uniformly labelled, Nuclear Chicago, Des Plains, Ill). Enzyme is incubated with this for 7-60 minutes when the reaction is stopped and protein coagulated by heating in a boiling waterbath for 2 minutes. The supernatant is spotted on 3 MM Whatman paper and subjected to high voltage electrophoresis in 4 x 10-2 M phosphate buffer (pH 6.4) at 50 v/cm. for 30 minutes, using a 30-inch flat plate apparatus (Savant Instruments, Inc., Hicksville, N.Y.) . After the paper is dried an autoradiogram on Kodak RB-54 film is made (24-48 hours exposure), which is used to locate aspartate and asparagine. Areas of paper 1-inch x 1 inch containing the amino acids are then cut out. These are counted by liquid scintillation in toluene PPO-POPOP (Liquifluor New England Nuclear, Boston). From measurements of the proportion of asparagine converted to aspartate, rates of hydrolysis can readily be calculated. The unit of asparaginase activity is that which hydrolyses 1 It mole asparagine in 1 hour. Blood asparagine levels. Methods for measurement are described elsewhere (Broome, 1966 (Broome, , 1968b .
Mice and tumors.-C3H or C3H/C57B1 F1 (Microbiological Associates, Bethesda, Maryland) weighing 20-25 g. have been used. Methods of implanting Lymphoma 6C3HED and its asparaginase-resistant sublines have been those described earlier (Broome, 1963; Schwartz, Reeves and Broome, 1966) .
EXPERIMENTAL RESULTS
Kinetics of agouti serum and E. coli asparaginases.
The conventional asparagine concentrations at which asparaginase assays are made are 1 x 10-2 to 5 x 10-3M (Broome, 1963; Mashburn et al., 1967) . As will be seen from Table I, E. coli and agouti serum asparaginases. At 1 X 10-4 M, however, the agouti serum enzyme is no longer saturated and acts with only 68 % of its maximal velocity, while the E. coli enzyme maintains full activity. The divergence between the behavior of the 2 enzymes becomes particularly marked at concentra-tions similar to those found physiologically. The average asparagine concentration in normal mouse blood is 2*5 x 10-5 moles/l. (Broome, 1968b) is in moles asparagine hydrolyaed/ml. agouti serum/hr.
These observations may be explained by further kinetic findings. Reciprocal plots of substrate concentration and velocity of enzyme action show in the case of E. coli asparaginase a linear graph to an asparagine concentration of at least 4 X 10-6 M. A Km value of 1-25 x 10-5 M (standard deviation 0*18 in 4 determinations) is found. But with agouti serum asparaginase the graph is linear only for the higher asparagine concentrations (Fig. 1 ). If these results alone are used an apparent Km of 4.11 x 10-5 (standard deviation 0-10 in 3 determinations) is obtained. At lower concentrations, below approximately half the apparent Km, the graph rises more steeply. This indicates an accelerated rate of fall in reaction velocity. Such reaction plots have been observed previously for several enzymes (Dixon and Webb, 1964) . In the present case the cause is unknown, but it is possible that the asparaginase is allosteric, that is, for maximal activity under the conditions now used, asparagine must simultaneously react with the enzyme molecule at more than one site. Differences in the kinetic properties of E. coli and agouti serum asparaginases are likely to be of importance in determining their biological effects. Certain other factors mayalso be significant. Relationship between blood asparagine levels and the rate of clearance of asparaginase from the blood When E. coli asparaginase is injected into normal mice in a tumor inhibitory dose, a profound fall in the blood asparagine level occurs, as shown in Fig. 3 , to become undetectably low 2 hours later. Asparaginase is cleared rapidly from the blood, in these experiments only 2 % of the initial activity is present at 12 hours. Nonetheless, the asparagine content of the blood is substantially reduced at this time (to 2 1 n moles/ml.). At 24 hours and 36 hours no asparaginase is detectable, yet blood levels of asparagine (8.0 and 11.5 n moles/ml.) are 28 % and 53 % of normal. Related findings occur with agouti serum enzyme, which is cleared from the blood much more slowly (Fig. 4) . By 72 hours the enzyme has almost completely disappeared from the blood, yet the blood asparagine level remains at only 20 % of normal. These results show that the effect of asparaginase continues after its removal from the blood. In the case of the E. coli enzyme they may be explained by findings in the liver. This tissue normally possesses very little asparaginase activity when measured at low substrate concentration (1 X 1O-4 M) while the E. coli enzyme is highly active under such conditions. Twenty-four hours after treating mice with this enzyme, when only small amounts remain in the blood or in the spleen, assays show approximately 5 times more asparaginase activity in the liver than in untreated controls (Table II) . It is likely that this represents sequestered E. coli enzyme, although activation or induction of liver enzyme has not been excluded. Whatever its nature, however, the presence of this asparaginase could have a significant effect on the asparagine content of the blood. The experiments described thus far have been performed Clearance of asparaginase from the blood of tumor-bearing mice Four days after implantation of asparaginase-sensitive cells of Lymphoma 6C3HED, and before palpable tumors have appeared, considerable changes are found in the rate of clearance of E. coli asparaginase from the blood, as may be seen in Fig. 5 . Semi-logarithmic plots of the results show that the average halflife of the enzyme in the blood of normal animals is 2-6 hours, while in those implanted with lymphoma cells this increases to 24* 1 hours. Six days later, when tumors of approximately 1-5 c. diameter have grown out, an essentially similar result is found; the half-life of enzyme in 3 animals is 205 ± 1-1 hours. A delay in clearance of enzyme is also found in animals bearing asparaginase-resistant 6C3HED 
DISCUSSION
These results show three factors which may be responsible for the particularly high tumor inhibitory effectiveness of the E. coli asparaginase in vivo. First, the enzyme is highly active at the low asparagine concentrations found physiologically. Secondly, a high asparaginase activity is found in the liver after the enzyme is removed from the blood, and blood asparagine levels remain low. Thirdly, persistence of enzyme in the blood is greatly prolonged after implantation of lymphoma cells.
In vitro asparaginase-sensitive cells of Lymphoma 6C3HED do not survive when the level of l-asparagine in the medium falls below 1 x 10-5 M (Broome, 1968b) . The relative importance of the degree of depression below this level for the development of cytotoxicity in sensitive tumor cells is not known. But from kinetic studies the E. coli enzyme would be expected to cause a more profound lowering of asparagine levels soon after injection than would the agouti serum asparaginase. Furthermore, tumor inhibition is likely to be increased by any factor which prolongs the depression of blood asparagine. This, it appears, results from raised asparaginase activity in the liver after E. coli enzyme is removed from the blood. Implantation with 6C3HED lymphoma cells causes a marked delay in clearance of E. coli asparaginase from the blood, and for these cells it is probably of considerable importance in determining the effectiveness of treatment.
The decreased rate of clearance of E. coli asparaginase from the blood of mice implanted with 6C3HED cells does not appear to be directly due to the tumor cells but rather to a transmissible agent carried by them. This has been shown by making a homogenate of 6C3HED cells, filtering it through " Millipore " discs of 0-22[t pore size, and injecting the filtrate intraperitoneally into 3 normal mice. After 4 days the half-life of injected E. coli asparaginase was found to be 19-7 + 0 9 hours in these animals while in a control group values of 2-6 + 0.1 hours were obtained. Next, 3 weeks later, the pooled blood plasma from each of the 2 groups of mice was injected into further normal animals. In 3 mice which had received 0 5 ml. plasma from animals given tumor cell filtrates, the half-life of asparaginase 4 days later was 21-3 + 1.1 hours, while in those given plasma from controls it was 2 8 + 0 5 hours. It is possible that these results are caused by the so-called " lactic dehydrogenase virus " or Riley agent which is carried by 6C3HED cells (Riley et al., 1960; Plagemann et al., 1963) . In the present experiments we have found a rise from an average in 4 normal mice of 403 lactic dehydrogenase units/ml. serum, assayed according to Wroblewski and LaDue (1955) , to an average of 2150 units/ml. 2 days after tumor cell implantation. The rise in blood lactic dehydrogenase and other endogenous enzymes after infection with the Riley agent has been shown to be associated with a decrease in the rate at which these enzymes are removed from the blood (Riley et al., 1965; Notkins, 1965) . The same mechanism may inhibit clearance of E. coli asparaginase. Further observations confirming this conclusion have recently been obtained by Riley and Campbell (1968, as yet unpublished) .
Taken together, the results now presented emphasize the varied factors which can influence the effectiveness of an asparaginase in bringing about tumor inhibition.
